The Patent Finder

Terms ending in 2037

Chemocentryx, Inc.

Every in-force patent on Chemocentryx, Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,285,138Method of Treating C3 Glomerulopathy
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,779,576Method of Treating C3 Glomerulopathy
In force
 · High confidence
Chemocentryx Inc.In forceHigh confidence
US 10,421,7482-Oxindole Compounds
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 10,759,7892-Oxindole Compounds
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,434,2302-Oxindole Compounds
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 12,139,4752-Oxindole Compounds
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 10,329,314SOLUBLE C5aR ANTAGONISTS
In force
 · Medium confidence
Chemocentryx, Inc.In forceMedium confidence
US 10,487,098SOLUBLE C5aR ANTAGONISTS
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 11,254,695SOLUBLE C5aR ANTAGONISTS
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
US 10,568,870Reducing Tumor Burden by Administering CCR1 Antagonists in Combination with PD-1 Inhibitors or PD-L1 Inhibitors
In force
 · High confidence
Chemocentryx, Inc.In forceHigh confidence
16 more term ends in 2037 · Pro
10 of 26 patents shown. Soonest term end first, then patent number.
Pro members see all 26.
Upgrade to Pro
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited